Previous Chapter Chapter 7: European Markets for Coronary Stents Next Chapter

  • Citations
  • Add to My List
  • Text Size

European Markets for Coronary Stents
European markets for coronary stents
Millennium Research Group, A Decision Resources, Inc. Company
Market Overview

The European coronary stent market, comprising drug-eluting stents (DES) and bare-metal stents (BMS), was valued in excess of $850 million in 2004. The use of coronary stents in percutaneous coronary interventions (PCIs) for the treatment of coronary artery disease (CAD) has risen rapidly over recent years. Currently, over 90% of PCI procedures in Europe involve a coronary stent because they have shown remarkable improvements in restenosis rates and patient outcomes compared to plain old balloon angioplasty (POBA).

Increased penetration of DES drove the growth of coronary stent units, procedures, ASPs, and revenues in 2004.

Stent procedures and units will continue to escalate over the forecast period but not as dramatically ...

Looks like you do not have access to this content.

Login

Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website